William Blair Investment Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224M Sell
2,174,594
-3,095,124
-59% -$201M 0.67% 29
2026
Q1
$250M Sell
5,269,718
-684,711
-11% -$30.7M 0.83% 15
2025
Q4
$189M Buy
5,954,429
+1,812,146
+44% +$56.5M 0.53% 44
2025
Q3
$117M Buy
4,142,283
+235,679
+6% +$7.14M 0.3% 91
2025
Q2
$144M Buy
3,906,604
+99,737
+3% +$3.45M 0.38% 78
2025
Q1
$149M Buy
3,806,867
+857,144
+29% +$38.6M 0.42% 68
2024
Q4
$137M Sell
2,949,723
-527,572
-15% -$23.8M 0.33% 95
2024
Q3
$157M Buy
3,477,295
+292,909
+9% +$13.9M 0.39% 90
2024
Q2
$157M Sell
3,184,386
-324,816
-9% -$13.2M 0.41% 78
2024
Q1
$120M Sell
3,509,202
-40,672
-1% -$1.47M 0.31% 95
2023
Q4
$131M Sell
3,549,874
-23,549
-0.7% -$545K 0.38% 90
2023
Q3
$72.4M Sell
3,573,423
-42,375
-1% -$931K 0.24% 116
2023
Q2
$74M Buy
3,615,798
+1,561,277
+76% +$23.4M 0.24% 115
2023
Q1
$31M Buy
2,054,521
+16,845
+0.8% +$372K 0.11% 215
2022
Q4
$48.5M Buy
2,037,676
+63,291
+3% +$1.84M 0.19% 122
2022
Q3
$69.6M Sell
1,974,385
-743,000
-27% -$31.6M 0.28% 106
2022
Q2
$95M Buy
2,717,385
+1,045,779
+63% +$37M 0.35% 97
2022
Q1
$82.5M Buy
1,671,606
+65,276
+4% +$3.62M 0.25% 117
2021
Q4
$124M Buy
1,606,330
+408,746
+34% +$42M 0.34% 99
2021
Q3
$128M Buy
1,197,584
+491,168
+70% +$56.2M 0.36% 95
2021
Q2
$94.1M Buy
706,416
+50,456
+8% +$5.87M 0.3% 110
2021
Q1
$81.2M Sell
655,960
-95,295
-13% -$14.5M 0.26% 111
2020
Q4
$106M Buy
751,255
+454,483
+153% +$50.4M 0.35% 99
2020
Q3
$22.5M Sell
296,772
-261,038
-47% -$16.3M 0.09% 183
2020
Q2
$25.3M Sell
557,810
-127,820
-19% -$4.59M 0.1% 170
2020
Q1
$21M Buy
+685,630
New +$18.4M 0.1% 173

Other funds holding TWST

William Blair Investment Management's TWST Position: Q2 2026 in Review

William Blair Investment Management reduced its Twist Bioscience (TWST) stake by 59% in Q2 2026, selling an estimated $201M and leaving 2,174,594 shares worth $224M. The position accounts for 0.67% of the portfolio, ranked #29.

William Blair Investment Management first reported a position in TWST in Q1 2020 and has held it in 26 quarters since. The position peaked at $250M in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • William Blair Investment Management held 2,174,594 shares of Twist Bioscience worth $224M as of Q2 2026.
  • William Blair Investment Management sold 3,095,124 Twist Bioscience shares in Q2 2026, an estimated $201M.
  • Twist Bioscience made up 0.67% of William Blair Investment Management's portfolio in Q2 2026, its #29 holding.
  • William Blair Investment Management first reported a position in Twist Bioscience in Q1 2020 and has held it in 26 quarters since.
  • William Blair Investment Management's Twist Bioscience position peaked at $250M in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.